tiprankstipranks
Advertisement

DGRO - ETF AI Analysis

Compare

Top Page

DGRO

iShares Core Dividend Growth ETF (DGRO)

Rating:73Outperform
Price Target:
DGRO’s rating reflects a solid mix of high‑quality, dividend‑growing companies, led by strengths like Microsoft, Apple, Johnson & Johnson, and Merck, which all show strong financial performance, growth initiatives, and supportive earnings outlooks. These leaders are partly offset by holdings such as AbbVie and Philip Morris, where high valuations, leverage, and financial stability concerns introduce some drag. The main risk factor is that several key holdings carry premium valuations or debt-related issues, which could weigh on returns if growth or cash flows disappoint.
Positive Factors
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of their returns over time.
Large Asset Base
With a very high level of assets under management, the ETF benefits from strong investor interest and typically better trading liquidity.
Broad Sector Diversification
Holdings are spread across financials, health care, technology, consumer sectors, and more, which helps reduce the impact of weakness in any single industry.
Negative Factors
Heavy U.S. Concentration
The portfolio is almost entirely invested in U.S. companies, offering very limited international diversification.
Mixed Performance Among Top Holdings
Several of the largest positions, including major technology and financial names, have shown weak year-to-date performance, which can drag on the fund’s results.
Limited Communication Services Exposure
Very small exposure to communication services means investors may miss potential gains if that sector performs strongly.

DGRO vs. SPDR S&P 500 ETF (SPY)

DGRO Summary

DGRO is the iShares Core Dividend Growth ETF, which follows the Morningstar US Dividend Growth Index. It invests mainly in large U.S. companies that have a history of steadily raising their dividends over time. Its holdings span many sectors, including financials, health care, and technology, and include well-known names like Microsoft and Apple. Someone might invest in DGRO to seek a mix of long-term growth and a growing stream of dividend income in one diversified fund. A key risk is that its stock prices and dividend-paying companies can still go up and down with the overall market.
How much will it cost me?The iShares Core Dividend Growth ETF (DGRO) has an expense ratio of 0.08%, which means you’ll pay $0.80 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down for investors.
What would affect this ETF?The iShares Core Dividend Growth ETF (DGRO) could benefit from stable economic growth and favorable interest rate conditions, which often support dividend-paying companies, especially in sectors like technology and healthcare. However, rising interest rates or economic downturns could negatively impact dividend growth and the performance of financial and consumer sectors, which are significant parts of the ETF's portfolio. Regulatory changes or sector-specific challenges, such as increased scrutiny on healthcare or technology companies, could also pose risks to its top holdings like Apple, Johnson & Johnson, and Microsoft.

DGRO Top 10 Holdings

DGRO leans heavily on classic U.S. dividend growers, with energy, health care, and tech sharing the spotlight. Exxon Mobil has been the main engine lately, rising and giving the fund a solid boost. In health care, Johnson & Johnson and Merck look steady to rising, helping to smooth out the ride. On the other hand, Apple and Microsoft have been losing a bit of steam, and JPMorgan and AbbVie are lagging, acting as mild brakes. Overall, it’s a U.S.-centric, blue-chip story with dividends doing the heavy lifting.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
JPMorgan Chase3.09%$1.19B$835.73B33.64%
72
Outperform
Broadcom2.97%$1.14B$1.76T112.91%
76
Outperform
Exxon Mobil2.94%$1.13B$635.47B47.64%
74
Outperform
Apple2.89%$1.12B$3.82T27.99%
79
Outperform
Johnson & Johnson2.81%$1.08B$574.36B54.16%
78
Outperform
Microsoft2.72%$1.05B$2.75T-0.89%
79
Outperform
AbbVie2.55%$983.64M$367.80B15.28%
66
Neutral
Procter & Gamble2.10%$809.07M$337.35B-15.11%
69
Neutral
Merck & Company2.00%$770.52M$300.20B51.76%
80
Outperform
Home Depot1.99%$768.34M$335.99B-4.49%
66
Neutral

DGRO Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
71.68
Positive
100DMA
70.57
Positive
200DMA
68.18
Positive
Market Momentum
MACD
0.15
Negative
RSI
61.83
Neutral
STOCH
90.03
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DGRO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 70.33, equal to the 50-day MA of 71.68, and equal to the 200-day MA of 68.18, indicating a bullish trend. The MACD of 0.15 indicates Negative momentum. The RSI at 61.83 is Neutral, neither overbought nor oversold. The STOCH value of 90.03 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DGRO.

DGRO Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$38.89B0.08%
73
Outperform
$587.54B0.03%
72
Outperform
$102.96B0.04%
72
Outperform
$83.85B0.03%
73
Outperform
$48.52B0.15%
75
Outperform
$42.40B0.17%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DGRO
iShares Core Dividend Growth ETF
72.29
14.77
25.68%
VTI
Vanguard Total Stock Market ETF
VIG
Vanguard Dividend Appreciation ETF
ITOT
iShares Core S&P Total U.S. Stock Market ETF
QUAL
iShares MSCI USA Quality Factor ETF
DFAC
Dimensional U.S. Core Equity 2 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement